Literature DB >> 21763628

RB1 gene mutations in Iranian patients with retinoblastoma: report of four novel mutations.

Ali Ahani1, Babak Behnam, Hamid Reza Khorram Khorshid, Mohammad Taghi Akbari.   

Abstract

Mutations in the RB1 gene lead to retinoblastoma, which is the most common intraocular tumor in children under the age of 6. In the present survey, the mutations of 18 unrelated Iranian retinoblastoma patients were characterized. Mutation analysis of the RB1 gene was performed in patients by sequencing all coding regions and by multiplex ligation probe-dependent amplification analysis. Clinical signs and symptoms of the retinoblastoma patients were similar to those of previously described patients with retinoblastoma. Eight known mutations and four novel mutations (c.832_833insT, c.1943delC, c.1206C>T, and c.2029delG) were determined. In silico analysis of the c.1206C>T variant showed that exon 12 contained an SC-35 consensus sequence, and this variation disrupted the splicing enhancer element and caused skipping of exon 12. Molecular genetic testing of retinoblastoma patients greatly affects the genetic counseling of the families involved, as well as the management of the disease in patients and at-risk relatives.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21763628     DOI: 10.1016/j.cancergen.2011.04.007

Source DB:  PubMed          Journal:  Cancer Genet


  8 in total

1.  Genetic screening in Iranian patients with retinoblastoma.

Authors:  K Shahraki; A Ahani; P Sharma; M Faranoush; G Bahoush; I Torktaz; W A Gahl; M Naseripour; B Behnam
Journal:  Eye (Lond)       Date:  2016-12-16       Impact factor: 3.775

2.  Genetic screening in patients with Retinoblastoma in Israel.

Authors:  Michal Sagi; Avishag Frenkel; Avital Eilat; Naomi Weinberg; Shahar Frenkel; Jacob Pe'er; Dvorah Abeliovich; Israela Lerer
Journal:  Fam Cancer       Date:  2015-09       Impact factor: 2.375

3.  A stepwise strategy for rapid and cost-effective RB1 screening in Indian retinoblastoma patients.

Authors:  Kannan Thirumalairaj; Aloysius Abraham; Bharanidharan Devarajan; Namrata Gaikwad; Usha Kim; Veerappan Muthukkaruppan; Ayyasamy Vanniarajan
Journal:  J Hum Genet       Date:  2015-06-18       Impact factor: 3.172

4.  Mutational screening of germline RB1 gene in Vietnamese patients with retinoblastoma reveals three novel mutations.

Authors:  Ha Hai Nguyen; Hoa Thi Thanh Nguyen; Nhung Phuong Vu; Quynh Thuy Le; Chau Minh Pham; Thuong Thi Huyen; Hung Manh; Hang Le Bich Pham; Ton Dang Nguyen; Hien Thi Thu Le; Hai Van Nong
Journal:  Mol Vis       Date:  2018-03-17       Impact factor: 2.367

5.  Spectrum of germline RB1 mutations and clinical manifestations in retinoblastoma patients from Thailand.

Authors:  Duangnate Rojanaporn; Tatpong Boontawon; Takol Chareonsirisuthigul; Onrampa Thanapanpanich; Taweevat Attaseth; Duangporn Saengwimol; Usanarat Anurathapan; Tharikarn Sujirakul; Rossukon Kaewkhaw; Suradej Hongeng
Journal:  Mol Vis       Date:  2018-12-09       Impact factor: 2.367

6.  Molecular Changes in Retinoblastoma beyond RB1: Findings from Next-Generation Sequencing.

Authors:  Jasmine H Francis; Allison L Richards; Diana L Mandelker; Michael F Berger; Michael F Walsh; Ira J Dunkel; Mark T A Donoghue; David H Abramson
Journal:  Cancers (Basel)       Date:  2021-01-05       Impact factor: 6.639

7.  Genotyping of Polymorphic Microsatellite Markers Linked to RB1 Locus in Iranian Population.

Authors:  Saman Mohamad Zahery; Kioomars Saliminejad; Hamid Reza Khorram Khorshid; Ali Ahani
Journal:  Avicenna J Med Biotechnol       Date:  2012-10

8.  Screening for large rearrangements of the RB1 gene in Iranian patients with retinoblastoma using multiplex ligation-dependent probe amplification.

Authors:  Ali Ahani; Mohammad Taghi Akbari; Kioomars Saliminejad; Babak Behnam; Mohammad Mehdi Akhondi; Parvaneh Vosoogh; Farriba Ghassemi; Masood Naseripour; Gholamreza Bahoush; Hamid Reza Khorram Khorshid
Journal:  Mol Vis       Date:  2013-02-22       Impact factor: 2.367

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.